Fig. 1From: Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panelCriteria to select patients with NDM for mexiletine (NaMuscla) treatment. Key: EKG, electrocardiogram; EMG, electromyographic; NDM, non-dystrophic myotonia. Note: The horizontal black line indicates the 70% consensus thresholdBack to article page